https://doi.org/10.1001/jama.2021.18178
A
Andrew Currie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
154
Papers
4.9K
Citations
40
h-index
88
i10-index
Andrew Currie is an academic researcher from Murdoch University. The author has contributed to research in topics: Neonatal Respiratory Health Research & Immunotherapy and Immune Responses & Immune Response and Inflammation. The author has an h-index of 40, co-authored 131 publications.
ORCID: 0000-0002-5193-3404Papers by this author
worksEffect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · JAMA · 209 citations
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
Sepsis-Induced Immunosuppression in Neonates
2018 · Frontiers in Pediatrics · 70 citations
https://doi.org/10.3389/fped.2018.00357
Early and sustained Lactobacillus plantarum probiotic therapy in critical illness: the randomised, placebo-controlled, restoration of gut microflora in critical illness trial (ROCIT)
2021 · Intensive Care Medicine · 54 citations
https://doi.org/10.1007/s00134-020-06322-w
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · JAMA · 45 citations
https://doi.org/10.1001/jama.2023.21407
Vancomycin Is Protective in a Neonatal Mouse Model of<i>Staphylococcus epidermidis</i>-Potentiated Hypoxic-Ischemic Brain Injury
2019 · Antimicrobial Agents and Chemotherapy · 20 citations
https://doi.org/10.1128/aac.02003-19
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat